ARC’s successful Diabetic Retinal Screening program featured in national publication
November 12, 2015
The new IRIS (Intelligent Retinal Imaging Systems) program currently screening diabetes patients in three ARC clinics has received recognition in Ophthalmology Management, an online industry publication. Dr. Anas Daghestani, Chief of ARC Internal Medicine and Director of Population Health and Clinical Quality, explains how and why the program has been successful in “helping to prevent the preventable” eye disease. An excerpt of his findings is below. Read his conclusion it it’s entirety here.
Helping to prevent the preventable
A primary care group learns that to detect diabetic retinopathies early, making the detection process convenient is vital.
By Anas Daghestani, MD
Diabetic retinopathy threatens the vision of more than 5 million U.S. adults over age 40. The leading cause of blindness in this country, diabetic retinopathy can affect anyone diagnosed with type 1 or type 2 diabetes, so blindness is a real possibility for millions of Americans. While diabetic retinopathy is highly treatable if caught early, data suggest fewer than half of diabetics keep up with the recommended annual eye screening.
Our primary care group has seen similar lackluster screening numbers among our diabetic patients. Despite years of proactive efforts — using electronic medical record alerts, mailing letters, making phone calls and delivering nagging in-person reminders — we barely moved the needle from a 45% compliance rate.
Our staff members wanted to change this dynamic and convince patients to get screened. It was only because of advancements in technology that we found a way to achieve it….
Continued at ophthalmologymanagement.com
Related: New Screening Saves Vision, Prevents Blindness